申请人:SHANGHAI iNSTITUTE OF MATERIA MEDICA ACADEMY OF SCIENCES
公开号:US20140128387A1
公开(公告)日:2014-05-08
Disclosed herein are protein kinase inhibitors, more particularly novel pyrimidine derivatives and pharmaceutical compositions thereof, and method of use thereof.
Holmberg, Acta Chemica Scandinavica (1947), 1956, vol. 10, p. 591
作者:Holmberg
DOI:——
日期:——
DEUTERIUM LABELLED DERIVATIVES OF 3-(2-HYDROXY-5-METHYPHENYL)-N,N-DIISOPROPYL-3-PHENYLPROPYLAMINE AND METHODS OF USE THEREOF
申请人:Liu Julie F.
公开号:US20110152227A1
公开(公告)日:2011-06-23
This invention relates to novel derivatives of tolterodine, 5-hydroxymethyl tolterodine, fesoterodine and pharmaceutically acceptable salts thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by muscarinic receptor antagonists.